1. Home
  2. POAI vs HSCS Comparison

POAI vs HSCS Comparison

Compare POAI & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Predictive Oncology Inc.

POAI

Predictive Oncology Inc.

HOLD

Current Price

$5.55

Market Cap

6.5M

Sector

Health Care

ML Signal

HOLD

Logo Heart Test Laboratories Inc.

HSCS

Heart Test Laboratories Inc.

HOLD

Current Price

$2.58

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
POAI
HSCS
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Medical Specialities
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5M
7.5M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
POAI
HSCS
Price
$5.55
$2.58
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
27.4K
39.6K
Earning Date
11-14-2025
12-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,664,407.00
$6,250.00
Revenue This Year
$486.27
N/A
Revenue Next Year
$65.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
320.71
N/A
52 Week Low
$4.76
$2.01
52 Week High
$45.90
$6.47

Technical Indicators

Market Signals
Indicator
POAI
HSCS
Relative Strength Index (RSI) 35.22 41.04
Support Level $5.31 $2.36
Resistance Level $6.00 $2.81
Average True Range (ATR) 0.55 0.26
MACD -0.00 -0.01
Stochastic Oscillator 7.16 49.12

Price Performance

Historical Comparison
POAI
HSCS

About POAI Predictive Oncology Inc.

Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.

About HSCS Heart Test Laboratories Inc.

HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.

Share on Social Networks: